Synopsys (SNPS) Just Locked Into Intel’s (INTC) Next Chip Node. What’s The Payoff?

Synopsys (NASDAQ: SNPS ) just extended its grip on the leading edge of chipmaking. On July 27, at the DAC Chips to Systems Conference, the company said it has certified its AI-powered design software for Intel's (NASDAQ: INTC ) upcoming 14A manufacturing process, building on flows it already runs in production on Intel's 18A and 18A-P nodes.

Synopsys's software and intellectual property sit underneath most of the advanced chips built today, and that is hard to dislodge once an engineering team standardizes around it. The Intel 14A work deepens that position. It folds power, thermal, and electromagnetic analysis directly into the design flow, and it extends Synopsys's 3DIC Compiler platform to support Intel's EMIB and EMIB-T packaging so engineers can plan multi-die chips instead of bolting dies together after the fact. New interface IP tied to the node, including PCIe 7.0 and 224G SerDes, is aimed at shaving time off getting a chip to tapeout.

The financial story tracks that positioning. Synopsys posted 42% year-over-year revenue growth in its fiscal 2026 second quarter and raised its full-year guidance, a sign demand from chipmakers is still climbing rather than leveling off. A separate look at fiscal 2025 showed revenue near $7.1 billion, up roughly 15.1%, with net income around $1.3 billion. Nvidia (NASDAQ: NVDA ) has expanded its own partnership with Synopsys alongside a $2 billion investment, and a Murata Manufacturing collaboration has already broadened the company's thermal and electromagnetic simulation models, the same multiphysics ground the Intel news now covers.

The stock has not moved in step with the business. Shares are down 12% year-to-date even as the company keeps taking share in its market, a gap that points to a valuation reset rather than a demand problem. Much of that comes back to the $35 billion Ansys acquisition. The deal expanded Synopsys well past chip design into broader engineering simulation, but the amortization tied to it has weighed on margins, and folding a company that size in carries real risk of operational friction and synergies that arrive slower than planned.

There is also a cash-quality wrinkle worth flagging. Stock-based compensation ran to roughly 58.8% of operating cash flow, which means the free cash flow figure leans heavily on a non-cash add-back rather than pure operating strength. On top of that, Synopsys is managing multiple class-action lawsuits alleging misstatements around its intellectual property segment, and a settlement with activist investor Elliott Investment Management leaves open the possibility of strategic changes ahead.

Hedge fund ownership slipped from 91 funds to 84 in the most recent quarter, a pullback that suggests some institutional investors trimmed positions even as the business grew. Short interest tells a different story: at just 2.94% of float, there is little organized betting against the stock. Shares trade at 24.10 times forward earnings as of August 10, a multiple that assumes continued growth but is not stretched for a company still expanding revenue at a double-digit clip.

Synopsys enters its next chapter with a stronger technical foothold and a messier balance sheet story than a year ago. The Intel 14A certification and the Nvidia and Murata relationships point to a company still setting the pace in chip design tools. For the bullish view to play out, the Ansys integration needs to stop weighing on margins and start adding to them.

While we acknowledge the potential of SNPS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock .